Sun Pharma Announces Regulatory Filing of Tildrakizumab in Japan
Japan is a key market with approximately 430,000 people currently suffering from psoriasis and psoriatic arthritis
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.